Smith & Nephew PLC ADR (SNN) News
Filter SNN News Items
SNN News Results
|Loading, please wait...|
SNN News Highlights
- For SNN, its 30 day story count is now at 5.
- Over the past 15 days, the trend for SNN's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about SNN are DOOR and PAY.
Latest SNN News From Around the Web
Below are the latest news stories about SMITH & NEPHEW PLC that investors may wish to consider to help them evaluate SNN as an investment opportunity.
Key Insights Smith & Nephew's estimated fair value is UK£17.05 based on 2 Stage Free Cash Flow to Equity Smith...
Smith & Nephew (SNN) will pay an initial cash consideration of $180 million at closure, with an additional $150 million based on financial performance to acquire CartiHeal.
Bioventus’ protracted buyout bid ultimately fell apart and opened the door to Smith & Nephew.
After losing 1.8% in the past year, Smith & Nephew plc (LON:SN.) institutional owners must be relieved by the recent gain
Key Insights Significantly high institutional ownership implies Smith & Nephew's stock price is sensitive to their...
As an investor its worth striving to ensure your overall portfolio beats the market average. But if you try your hand...
Smith+Nephew opens new state-of-the-art surgical innovation and training centre in the heart of Munich
Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company specialising in orthopaedics, advanced wound management and sports medicine, is pleased to announce the opening of the purpose-built Smith+Nephew Academy Munich, a new centre for surgical innovation and training.
Smith & Nephew PLC(NYSE:SNN) recently announced a dividend of $0.29 per share, payable on 2023-11-01, with the ex-dividend date set for 2023-10-05. Using the data from GuruFocus, let's deep dive into Smith & Nephew PLCs dividend performance and assess its sustainability. Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions.
Abbott Laboratories, Koninklijke Philips and Smith & Nephew are included in this Analyst Blog.
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Here we pick three stocks, Abbott Laboratories (ABT), Koninklijke Philips (PHG) and Smith & Nephew SNATS (SNN) from the Medical - Products industry, with a solid five-year dividend growth history.